Actively Recruiting
Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
Led by University Hospital, Bordeaux · Updated on 2024-07-08
200
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Bordeaux
Lead Sponsor
I
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
A collection of biological samples (skin) will be created to meet the objectives. Skin biopsies will be taken (excluding on face and fold), in accordance with standard practice.
CONDITIONS
Official Title
Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 or over
- Patients with suspected actinic keratosis or cutaneous squamous cell carcinoma lesions (in situ, infiltrating or metastatic)
- Patients able to sign a consent form
- Patients affiliated to a French Social Security system
You will not qualify if you...
- Patients who have previously received systemic treatment such as chemotherapy or immunotherapy
- Patients with lesions located on visible zones of the face or skin folds
- Patients under guardianship or curatorship
- Patients not affiliated to a French Social Security system
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital of Bordeaux - Department of Dermatology
Bordeaux, France, 33000
Actively Recruiting
Research Team
M
Marie BEYLOT-BARRY, MD, PhD
CONTACT
C
Christine ALFARO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here